http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160104217-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_046b94174ff188b5b5d0c4605583ee11 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-19 |
| filingDate | 2015-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f834b22e546f69c715cb6cbf03e8f5c5 |
| publicationDate | 2016-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20160104217-A |
| titleOfInvention | Pharmaceutical Composition for Preventing or Treating a Glaucoma Comprising Blood Components as Active Ingredients |
| abstract | The present invention relates to a pharmaceutical composition for preventing or treating glaucoma comprising a blood component as an active ingredient. According to the present invention, when monocyte extract or platelet extract is directly injected into the glaucoma-induced eyeball, the increase of glaucoma-induced glaucoma is mitigated, the retinal ganglion cell damage is protected, and the visual acuity is improved. Therefore, a composition comprising the blood component of the present invention as an active ingredient can be used for the development of a therapeutic agent for glaucoma. |
| priorityDate | 2015-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 105.